Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > ASH December 5 to 8

View:

Post by Lesalpes29 on Nov 26, 2020 8:36am

ASH December 5 to 8

Pelareorep and Opdivo Phase 1 intrim data due at ASH. Found that on biopharmcatalyst. Do we know for sure if they are going to present data?

933

Comment

Comment by YegJeeber on Nov 26, 2020 1:12pm

I spoke with Kirk Look yesterday, and he confirmed ONCY is not participating in ASH, nor are any collaborators in Pelareorep based trials. Have no idea what BioPharmaCatalyst is doing noting that .....

266

Comment

Comment by canadafan on Nov 26, 2020 7:46pm

Perhaps a miss-name of the event? as ONC is clearly reporting as noted bellow: :Not only are they presenting one-but 3 separate trial results. That being the week of Dec 5-8th.perhaps being on the 9th confused people as not within the 5-8th week..lol //stockhouse.com/news/press-releases/2020/11/17/oncolytics-biotech-xae-to-present-aware-1-data-and-provide-updates-on-phase-2 Sanantonio Brest ...more

319

Comment

Comment by JohnnyYeg on Nov 26, 2020 9:08pm

Actually I saw the screenshot of the Biopharmacatalyst.com. webpage that "promoted" ONC at the ASH event. It was obviously something they were trying to again promote. Makes me question their integrity.

392

Comment

Oncolytics Biotech Inc